We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MFC:NYSEManulife Financial Corporation Analysis

Data as of 2026-08-23 - not real-time

$42.51

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At $42.51, Manulife Financial Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 3.0%. With RSI at 40.5 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $41.68 and resistance around $45.33.
Valuation screens as fair: a P/E of 15.9 sits in line with the sector average of 16.8. Sell-side targets cluster 18.5% below the current quote. Revenue is growing at 10.7% on a 20.3% profit margin. The 3.20% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 17.9%, a beta of 0.76 and a maximum drawdown of 13.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.

Top Market Events

Updated May 21, 2026 0 C$ unless otherwise stated                                   �...Manulife delivers strong double-digit growth across key segments while executing a third long-term care reinsurance...Manulife Financial Corporation will release its second quarter 2026 financial results after markets close on Wednesday,...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 37.96
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 15.9 versus sector average of 16.8
  • Trading above the 200-day average of 37.96

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 15.9 versus sector average of 16.8
  • Analyst targets imply -18.5% versus the current price
  • Profit margin of 20.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth10.70%
Profit Margin20.31%
P/E Ratio15.9
ROE13.31%
ROA0.60%
Debt/Equity42.48
P/B Ratio1.9
Op. Cash Flow$31.0B
Free Cash Flow$1.5B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI40.5
Support$41.68
Resistance$45.33
MA 20$44.05
MA 50$42.45
MA 200$37.96
MACDBearish
VolumeIncreasing
Fear & Greed Index94.41

Valuation

Fair Value$24.43
Target Price$34.65
Upside/Downside-18.48%
GradeFair
TypeBlend
Dividend Yield3.20%

Risk Assessment

Beta0.76
Volatility17.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.